In recent advancements within the realm of breast cancer therapy, the CompassHER2 pCR trial emerges as a beacon of hope...
A comprehensive new study has shed light on the nuanced differences in colorectal adenoma prevalence between younger and older adults,...
A novel prognostic indicator known as the platelet-neutrophil-monocyte-lymphocyte ratio (PNMLR) has recently emerged from a comprehensive study evaluating survival outcomes...
In a groundbreaking development in the treatment of rare hematologic malignancies, researchers have unveiled promising results for a novel antibody-drug...
In a groundbreaking advance poised to reshape the landscape of cancer immunotherapy, researchers have uncovered compelling evidence that specific antioxidants...
A groundbreaking study conducted by researchers at Fox Chase Cancer Center, unveiled at the prestigious American Society of Clinical Oncology’s...
A groundbreaking study emerging from the prestigious UCLA Health Jonsson Comprehensive Cancer Center has unveiled compelling evidence that the immunotherapy...
In a groundbreaking development that promises to redefine prognostic evaluation in pediatric oncology, researchers have unveiled the pan-immune-inflammation value (PIV)...
In a groundbreaking study published in the prestigious Proceedings of the National Academy of Sciences, researchers from Cornell University have...
In a groundbreaking study published in BMC Cancer, researchers have unveiled the remarkable efficacy of targeting the oncogenic regulator mdm2...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine